Melinta Therapeutics’ $1 Billion Acquistion of Infectious Disease Business from The Medicines Company

Willkie and Cadwalader, Wickersham & Taft LLP advised on the deal Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

SBM Offshore’s FCPA Settlement with U.S. Authorities in Connection with Petrobras and Other Legacy Bribery Issues

Cravath client SBM Offshore N.V. (“SBM”), a Netherlands-based provider of floating production solutions to the offshore energy industry, reached a settlement with the U.S. Department of...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here